58 unknown. 58 Phase 3, 17 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 58 | Unknown 58 |
| Phase 2 | 17 | Unknown 17 |
Follow Overweight: new trials by email Literature Review of Overweight trials Research Report on Overweight
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Triticum Aestivum on Appetite, Ghrelin, Leptin, Adiponectin Hormonal Axis in Patients With Obesity Triticum Aestivum, Placebo (calcined magnesia) - Obesity, Leptin Deficiency | Phase 3 | Unknown | Coordinación de Investigación en Salud, Mexico | 38 | 2024-01-03 | 2024-07-11 |
| A Study of IBI362 9 mg in Chinese Adults With Obesity IBI362, Placebo - Obesity | Phase 3 | Unknown | Innovent Biologics (Suzhou) Co. Ltd. | 462 | 2023-12-27 | 2024-08-27 |
| Liraglutide and Metformin Combination on Weight Loss, Metabolic - Endocrine Parameters and Pregnancy Rate in Women With PCOS, Obesity and Infertility Liraglutide + Metformin, Metformin - Polycystic Ovary Syndrome, Obesity | Phase 3 | Unknown | Mỹ Đức Hospital | 188 | 2023-11-01 | 2023-10-23 |
| Laparoscopic Guided Peri-wound Transversus Abdominis Plane Block With Bupivacaine Versus Local Wound Infiltration on Post-op Opioid Use in Laparoscopic Sleeve Gastrectomy peri-wound Transversus Abdominis Plane Block, Local wound infiltration - Morbid Obesity, Laparoscopic Sleeve Gastrectomy | Phase 2 / Phase 3 | Unknown | Khon Kaen University | 98 | 2023-04-29 | 2024-05-01 |
| Xian-Hua-Cha for Relieving Hyperlipidemia With Obesity Xian-Hua-Cha - Hyperlipidemias, Obesity | Phase 3 | Unknown | Chang Gung Memorial Hospital | 100 | 2022-12-13 | 2024-10-08 |
| Effect of Triticum Aestivum vs Placebo on Metabolic Profile Components and Insulin Sensitivity in Patients With Obesity Triticum Aestivum, Placebo (calcined magnesia) - Obesity, Drug Effect | Phase 3 | Unknown | Coordinación de Investigación en Salud, Mexico | 36 | 2022-07-14 | 2024-07-15 |
| Dose of Magnesium Sulfate Infusion in Obese Lactate ringer group, Magnesium sulfate dose through real weight group, Magnesium sulfate dose through corrected ideal weight group - Obese, Analgesia | Phase 3 | Unknown | University of Sao Paulo General Hospital | 75 | 2022-04-01 | 2023-10-31 |
| Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial Follow-up study of the treated cohort, Follow-up study of the untreated cohort - Prader-Willi Syndrome | Phase 3 | Unknown | University Hospital, Toulouse | 80 | 2021-09-07 | 2024-04-30 |
| Naldebain for Pain Control After Bariatric Surgery Dinalbuphine sebacate, Placebo solution - Pain, Postoperative, Pain, Chronic | Phase 2 / Phase 3 | Unknown | E-DA Hospital | 60 | 2021-06-24 | 2021-12-28 |
| Ketamine Infusion vs Dexmedetomidine Infusion in Obese Patients Undergoing Bariatric Surgery Ketamine, Dexmedetomidine, Normal Saline 0.9% - Morbid Obesity, Surgery | Phase 3 | Unknown | Ain Shams University | 90 | 2021-04-20 | 2021-07-28 |
| Gut Microbiome Changes Following Liraglutide Treatment in Obese Subjects or Overweight Subjects With Co-morbidities Liraglutide, placebo - Obesity | Phase 3 | Unknown | Xiangya Hospital of Central South University | 300 | 2020-05-24 | 2020-08-25 |
| Efficacy and Safety of Liraglutide on Body Weight in Obese Subjects or Overweight Subjects With Co-morbidities Liraglutide, placebo - Obesity | Phase 3 | Unknown | Xiangya Hospital of Central South University | 300 | 2020-05-09 | 2020-07-27 |
| Intra-gastric Fundal and Body Injection of Botulinum Toxin A for Weight Loss, a Randomized Controlled Trial Botulinum toxin type A, Weight Management Program - Obesity, Weight Loss | Phase 2 / Phase 3 | Unknown | Tan Tock Seng Hospital | 18 | 2020-01-01 | 2020-02-18 |
| Effects of Benaglutide on Weight and Gut Microbiota in Obese Patients Benaglutide, Liraglutide - Obesity | Phase 3 | Unknown | Xiangya Hospital of Central South University | 60 | 2019-12-01 | 2021-04-09 |
| Effect of Tadalafil Administration on Vasodilatation Mediated by Flow in Patients With Obesity Grade I-II Tadalafil 20 MG - Obesity and Erectile Dysfuntion | Phase 3 | Unknown | Centro Universitario de Ciencias de la Salud, Mexico | 80 | 2019-05-01 | 2019-04-05 |
| ReShape Vest™ for the Treatment of Obesity (Europe) Laparoscopic Gastric Vest (LGV) - Obesity, Weight Loss | Phase 2 / Phase 3 | Unknown | ReShape Lifesciences | 65 | 2019-03-25 | 2020-02-24 |
| The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters. Glycine - Metabolic Syndrome, Dyslipidemias | Phase 2 / Phase 3 | Unknown | Prof. Tony hayek MD | 50 | 2019-03-01 | 2019-02-21 |
| Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients Liraglutide, Exenatide, Exenatide Microspheres for Injection - Obesity | Phase 3 | Unknown | Xiangya Hospital of Central South University | 150 | 2018-09-01 | 2021-04-09 |
| A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome Recombinant Human Growth Hormone (rhGH) Injection - Prader-Willi Syndrome | Phase 3 | Unknown | Changchun GeneScience Pharmaceutical Co., Ltd. | 30 | 2018-04-14 | 2018-06-12 |
| Intranasal Glucagon and Energy Balance Glucagon, Placebo - Obesity | Phase 2 / Phase 3 | Unknown | University Health Network, Toronto | 20 | 2017-06-06 | 2018-08-31 |
Showing 20 of 58. Sign in to see all of them.
Obesity (47) · Obesity, Morbid (10) · Diabetes Mellitus, Type 2 (5) · Insulin Resistance (5) · Weight Loss (5) · Diabetes Mellitus (3) · Dyslipidemias (3) · Metabolic Syndrome (3) · Body Weight (2) · Breast Neoplasms (2) · Hypertension (2) · Inflammation (2) · Prader-Willi Syndrome (2) · Respiratory Aspiration (2)
Nutrition Disorders (58) · Nutritional and Metabolic Diseases (58) · Overnutrition (58) · Pathological Conditions, Signs and Symptoms (56) · Signs and Symptoms (56) · Body Weight (54) · Metabolic Diseases (17) · Glucose Metabolism Disorders (15) · Endocrine System Diseases (11) · Obesity (10) · Hyperinsulinism (8) · Diabetes Mellitus (7) · Pathologic Processes (7) · Body Weight Changes (5)
Liraglutide (6) · Metformin (3) · Exenatide (2) · Flour (2) · Ketamine (2) · Sugammadex (2) · 5,10-dihydro-5-methylphenazine (1) · Alprostadil (1) · Botulinum Toxins, Type A (1) · Brachytherapy (1) · Butyrates (1) · Capsaicin (1) · Carboplatin (1) · Combined Modality Therapy (1) · Counseling (1)
Xiangya Hospital of Central South University (4) · Chinese University of Hong Kong (2) · Coordinación de Investigación en Salud, Mexico (2) · University of Padova (2) · University of Patras (2) · Advanced Specialty Care (1) · Ain Shams University (1) · Biopolis S.L. (1) · Bridgeport Hospital (1) · Brigham and Women's Hospital (1) · Centro Universitario de Ciencias de la Salud, Mexico (1) · Chang Gung Memorial Hospital (1) · Changchun GeneScience Pharmaceutical Co., Ltd. (1) · Charite University, Berlin, Germany (1) · Children's Hospital of Eastern Ontario (1)
China (9) · United States (8) · Mexico (5) · Brazil (3) · Israel (3) · Italy (3) · South Korea (3) · Spain (3) · Australia (2) · Canada (2) · Greece (2) · Taiwan (2) · Belgium (1) · Egypt (1) · France (1)
Jing Wu (3) · Ahmed N El-Shaer, PhD (1) · Almantas Maleckas (1) · Antonio Peralta, MD (1) · Asnat Walfisch, MD (1) · Athena Siampalioti, M.D. (1) · Athina Siampalioth, MD (1) · Ayman M Arafat, Dr.med. (1) · Bahaa El-Din E Ali, PhD (1) · Belal N Khalil, M.Sc (1) · Bruna Pontin, MD (1) · Bruno Geloneze, MD, PhD (1) · Carl-Erik Flodmark, MD, PhD (1) · Chen-Fuh Lam, MD, PhD (1) · Clude Marcus, Prof, MD (1)
PMID 11527911, PMID 14688154, PMID 17980364, PMID 18068166, PMID 18364705, PMID 19056992, PMID 19640956, PMID 19841045, PMID 20124139, PMID 22117618, PMID 22767467, PMID 23966238, PMID 24151290, PMID 24362411, PMID 24491362, PMID 24581574, PMID 24789668, PMID 25682903, PMID 25710812, PMID 26401593, PMID 2670645, PMID 27071497, PMID 27459230, PMID 28065734, PMID 28479118, PMID 28681988, PMID 28760517, PMID 28961722, PMID 29063494, PMID 29703793, PMID 30033227, PMID 30660196, PMID 30995174, PMID 31031702, PMID 31229399, PMID 31238940, PMID 31733195, PMID 31978372, PMID 32442310, PMID 33079376, PMID 33552465, PMID 34583840, PMID 36996264, PMID 37005580, PMID 40144953, PMID 42251595
U10CA027469 (1), U10CA180868 (1)